What drugs does GENUS LIFESCIENCES make?

GENUS LIFESCIENCES has 9 FDA-approved drugs including POKONZA.

What therapeutic areas does GENUS LIFESCIENCES focus on?

GENUS LIFESCIENCES focuses primarily on Metabolic and Oncology.

← Back

Data updated: Mar 10, 2026

GENUS LIFESCIENCES

MetabolicOncology

Pharma

GENUS LIFESCIENCES is a pharmaceutical company focused on Metabolic, Oncology. Key products include POKONZA.

1981

Since

Drugs

Trials

181

Approved (2yr)

Key Drugs

POKONZA

potassium chloride

2 indications · 2014

Recent Activity

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

OXYCODONE HYDROCHLORIDE 2026-01-06

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 67%

2 drugs

Oncology 33%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Merck big-pharma

Oncology, Metabolic

Johnson & Johnson big-pharma

GENUS LIFESCIENCES

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (9)

Active (5)

Discontinued (4)

Company Info